Word

LINNEA 315CSE

Status

Registered

Status Code

700

Status Date

Tuesday, May 18, 2021

Serial Number

88589105

Registration Number

6351234

Registration Date

Tuesday, May 18, 2021

Mark Type

4000

Filing Date

Thursday, August 22, 2019

Published for Opposition

Tuesday, July 21, 2020

Trademark Owner History

LINNEA S.A. - Original Registrant

Classifications

5 Pharmaceuticals derived from botanical and plant extracts; pharmaceuticals derived from botanical and plant extracts for veterinary purposes; pharmaceuticals derived from botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; medicines for veterinary purposes; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts for pharmaceutical and veterinary purposes; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; plant extracts, active substances and active chemical ingredients for veterinary use; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the cosmetics industry; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system

1 Chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; botanical extracts, active substances and active chemical ingredients for use in the manufacture of veterinary preparations; plant extracts, active compounds and active chemical ingredients for use in the manufacture of pharmaceuticals; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; chemicals for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and dietary supplements; food preserving chemicals; plant extracts, active substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements

LINNEA THREE HUNDRED FIFTEEN CSE; LINNEA THREE ONE FIVE CSE

Trademark Events

Mar 6, 2024

Teas Section 7 Request Received

May 18, 2021

Registered-Principal Register

Apr 9, 2021

1(B) Basis Deleted; Proceed To Registration

Jan 20, 2021

Notice Of Allowance Cancelled

Apr 9, 2021

Case Assigned To Intent To Use Paralegal

Jan 20, 2021

Teas Delete 1(B) Basis Received

Sep 15, 2020

Noa E-Mailed - Sou Required From Applicant

Jul 21, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 21, 2020

Published For Opposition

Jul 1, 2020

Notification Of Notice Of Publication E-Mailed

Jun 16, 2020

Approved For Pub - Principal Register

Jun 11, 2020

Teas/Email Correspondence Entered

Jun 11, 2020

Correspondence Received In Law Office

Jun 11, 2020

Assigned To Lie

Jun 3, 2020

Teas Response To Office Action Received

Dec 4, 2019

Notification Of Non-Final Action E-Mailed

Dec 4, 2019

Non-Final Action E-Mailed

Dec 4, 2019

Non-Final Action Written

Nov 21, 2019

Assigned To Examiner

Sep 9, 2019

New Application Office Supplied Data Entered

Aug 26, 2019

New Application Entered